Eurosurveillance banner


Eurosurveillance invites authors to submit papers for a special issue on HIV/AIDS and other sexually transmitted infections (STI) in men who have sex with men (MSM). The topic is in line with the main theme of World AIDS Day 2009 events organised by the European Centre for Disease Prevention and Control and aims at drawing attention to the epidemiological importance of MSM in HIV and other STI and directing the ECDC activities to focus on main risk groups.

Eurosurveillance is planning to publish a special issue on Socio-economic determinants and infections diseases in Europe in spring 2010. For this reason Eurosurveillance invites interested scientists who have research findings in the area to submit papers for review and possible publication. The submission deadline now is 15 November.

The data from 27 European Union countries plus Iceland, Liechtenstein and Norway show that considerable progress has been made in preventing and controlling the disease. The number of newly diagnosed cases and the overall notification rate declined continuously in the past decade, and the notification rate in 2007 was 12% lower than in 2003. In spite of this decline, a total of 84,917 new cases of TB were registered in 2007 and a number of challenges hamper the progress towards the elimination of TB in the EU.

A number of bacterial and viral infections in pregnant women can have serious effects on the unborn child leading to impaired mental and physical health later in life. This week’s issue of Eurosurveillance is dedicated to infectious diseases in pregnancy.

The emergence and spread of antimicrobial resistance (AMR) is a growing problem in many European countries. To mark the very first European Antibiotic Awareness Day, on 18 November, the scientific journal Eurosurveillance runs a series of articles to highlight main aspects of the AMR problem in Europe. They will be published in two issues on 13 and 20 November 2008.

In preparation for the coming influenza season 2008-9, Eurosurveillance publishes a special issue on prevention of influenza by vaccination. Seasonal influenza poses a serious public health threat because of associated serious morbidity and mortality. In Europe, estimates suggest that influenza is responsible for around 40,000 to 220,000 excess deaths, depending on the severity of the epidemic.

Today Eurosurveillance is publishing a special issue dedicated to the widespread advances made in Europe in estimating the real number of newly acquired HIV infections based on an innovative approach called STARHS

To tie in with World Hepatitis Day on 19 May, the scientific journal Eurosurveillance is today publishing a special issue on viral hepatitis, highlighting issues and challenges related to hepatitis B and C.

On 17 April 2008, Eurosurveillance is publishing a special issue with articles on the measles situation in Europe. The publication is linked to European Immunisation Week which runs from 21-27 April.

World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings of the causing agent of tuberculosis (TB) – Mycobacterium tuberculosis. In the run up of this day Eurosurveillance publishes a special issue on the situation of TB in Europe.

Today (6 March, 2008), Eurosurveillance, the European peer-reviewed journal of infectious diseases, publishes a special issue on meningococcal disease. It includes two in-depth articles and an editorial by the European Centre for Disease Prevention and Control (ECDC).


In this issue


Home Eurosurveillance Weekly Release  1998: Volume 2/ Issue 13 Article 1 Printer friendly version
Back to Table of Contents
Next

Eurosurveillance, Volume 2, Issue 13, 26 March 1998
Articles

Citation style for this article: Maillot E. Sale of raw milk in France. Euro Surveill. 1998;2(13):pii=1238. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=1238

Sale of raw milk in France

In France, the sale of raw milk destined for human consumption is authorised but strictly controlled by a ruling of the Ministry of Agriculture of 1985, which provides for different levels of restrictions. In this way, all those responsible for the production of raw milk destined for human consumption are obliged to:
  • register with nearby veterinary services for licensing;
  • declare the absence of clinical cases of Q fever and possess a health licence, which specifies among others the following conditions:
    • unblemished record of no brucellosis and tuberculosis (annual tuberculin testing)
    • strict hygienic conditions regarding local equipment (accommodation, local storage of milk), animal husbandry, good practice, cooling of milk, and cleaning/disinfection of material
    • - well maintained register of the health of individual consignments and identification of livestock
  • define precise methods used to package milk (materials, place, time limit);
  • label containers with a DLC (date limit for consumption): Jc (date of packaging) plus 3 days if individually packaged on the farm; and Jp (day of production) plus 48 hours in the case of distribution in bulk in containers;
  • inscribe an operating license number on the carton or the container (to facilitate tracing);
  • verify with the regulatory authorities the conformity of raw milk to cellular, microbiological, and chemical criteria. Somatic cells are measured to indicate the health of the udder. Microbiological criteria are listed in the table. Milk is also examined for residual bacteria, antibiotics, or antifungicides;
  • control conditions of transportation and preservation of milk (4°C).

Raw milk for human consumption is included in the category of "foods that have not undergone decontamination treatment or are susceptible to recontamination after treatment". A service note in 1993, in the process of revision, anticipates that Listeria monocytogenes will be absent at the time of production, and not exceed 100 organisms per gram at the time of consumption, in conformity with a recommendation of the Council Supériore d’Hygiène Publique de France.

Table: Microbiological quality criteria for raw milk destined for human consumption

Raw milk must be free from microorganisms and dangerous toxins to satisfy the following public health criteria:

Designation Aerobic microorganisms at 30ºC (per ml) Faecal coliforms (per ml) Salmonellas (in 1000 ml) Beta haemolytic streptococci* (in 0.1 ml) Stable boiling point Acidity (grams of lacticacid per 1000 ml)
Day of packaging** <90,000 <100 Absent Absent ~ ~
‘Use by’ date <300,000 <100 Absent Absent Stable 1.4 - 1.8

* only beta haemolytic streptococci of Lancefield groups A, B, C, G, and L.
** or on day of production (non-packaged or individually packed raw milk

Reported by Evelyne Maillot, Réseau National de Santé Publique, Saint Maurice, France

back to top



Back to Table of Contents
Next

Disclaimer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our Website does not host any form of commercial advertisement.

Eurosurveillance [ISSN] - ©2008 All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.